Search

Your search keyword '"Dorta, Miriam Leandro"' showing total 117 results

Search Constraints

Start Over You searched for: Author "Dorta, Miriam Leandro" Remove constraint Author: "Dorta, Miriam Leandro"
117 results on '"Dorta, Miriam Leandro"'

Search Results

3. Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees

6. AVALIAÇÃO DE FATORES QUE IMPACTAM NA INCIDÊNCIA DE RECIDIVAS DE LEISHMANIOSE TEGUMENTAR OU LEISHMANIOSE VISCERAL EM PACIENTES CO-INFECTADOS COM O VÍRUS DA IMUNODEFICIÊNCIA HUMANA

8. New world Leishmania spp. infection in people living with HIV: Concerns about relapses and secondary prophylaxis

12. Genetic variation in Interleukin-32 influence the immune response against New World Leishmania species and susceptibility to American Tegumentary Leishmaniasis

15. Alterations in monocyte subsets and cytokine production after TLR activation in American Cutaneous Leishmaniasis

16. Case Report: Atypical Cutaneous Leishmaniasis in a Patient with Mixed Leishmania guyanensis and Leishmania amazonensis Infection

17. Human Interleukin-32γ Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice

18. American tegumentary leishmaniasis: epidemiological and molecular characterization of prevalent Leishmania species in the State of Tocantins, Brazil, 2011-2015

20. Analysis of the Interactions of Amphotericin B with the LeishmaniaPlasma Membrane Using EPR Spectroscopy

22. IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis

24. Decreased Toll-Like Receptor 2 and Toll-Like Receptor 7/8-Induced Cytokines in Parkinson's Disease Patients

25. Performance of two immunochromatographic tests for diagnosis of visceral leishmaniasis in patients coinfected with HIV.

26. TLR4 and TLR2 activation is differentially associated with age during Parkinson’s disease.

27. Biofilms of black tooth stains: PCR analysis reveals presence of Streptococcus mutans

28. Leishmania spp. parasite isolation through inoculation of patient biopsy macerates in interferon gamma knockout mice

29. Identification and Biological Characterization ofLeishmania (Viannia) guyanensisIsolated from a Patient with Tegumentary Leishmaniasis in Goiás, a Nonendemic Area for This Species in Brazil

30. In VitroMetacyclogenesis ofLeishmania (Viannia) braziliensisandLeishmania (Leishmania) amazonensisClinical Field Isolates, as Evaluated by Morphology, Complement Resistance, and Infectivity to Human Macrophages

31. IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.

34. Interleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10

37. In Vitro Metacyclogenesis of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Clinical Field Isolates, as Evaluated by Morphology, Complement Resistance, and Infectivity to Human Macrophages.

38. Terpenes Increase the Lipid Dynamics in the Leishmania Plasma Membrane at Concentrations Similar to Their IC50 Values.

39. Leishmania spp. PARASITE ISOLATION THROUGH INOCULATION OF PATIENT BIOPSY MACERATES IN INTERFERON GAMMA KNOCKOUT MICE.

40. Miltefosine Increases Lipid and Protein Dynamics in Leishmania amazonensisMembranes at Concentrations Similar to Those Needed for Cytotoxicity Activity

41. Leishmania (Viannia) braziliensis amastigotes induces the expression of TNFα and IL-10 by human peripheral blood mononuclear cells in vitro in a TLR4-dependent manner.

42. Diagnosis of leishmaniasis in Felis catus domesticus from endemic urban area of northern region of Brazil

43. Standardization of PCR / RFLP product analysis that amplifies the Ribosomal Internal Transcribed spacer (ITS) and Glucose- 6-phosphate dehydrogenase (G6PD) genes for identification of Leishmania spp. in polyacrylamide gel

44. Evaluation of monocytes from patients with tegumentary leishmaniasis before and after treatment

45. Evaluation of the use of immunoglobulin E (IgE) anti - leishmania as marker of prognosis in american Tegumentary leishamaniasis

46. Evaluation of innate immune response cell recruitment by BCG Moreau in the absence of cytokine IL-17 and IL-22

47. Evaluation of accuracy of tests immunochromatographic rK39 in diagnosis of visceral leishmaniasis in patients coinfected with HIV

48. Cutaneous Leishmaniasis in the Midwest region: review of clinical, epidemiological, laboratory and molecular data

49. Evaluation of antigenicity of recombinant proteins of L. (V.) braziliensis

50. In vitro evaluation of metacyclogenesis of L. (V.) braziliensis e L. (L.) amazonensis

Catalog

Books, media, physical & digital resources